1-acyl-5-phenyl-1h-1,5-benzodiazephine-2,4-{8 3h,5h{9 -diones

ABSTRACT

1-Acyl-5-phenyl-1H-1,5-benzodiazepine-2,4-(3H,5H)-diones of the formula   WHEREIN R1 is hydrogen, straight-chain alkyl of one to 15 carbon atoms, halomethyl, methylamino, alkoxy of one to two carbon atoms, cyclohexyl, phenyl, halophenyl, methylphenyl, methoxyphenyl, nitrophenyl, benzyl, styryl or a five-membered heterocyclic ring comprising a sulfur or oxygen atom, R2 is hydrogen, halogen, methyl or methoxy, and R3 is hydrogen or halogen, methyl or trifluoromethyl in the 7or 8-position, WHICH ARE USEFUL AS PSYCHOSEDATIVES, MUSCLE RELAXANTS AND ANTICONVULSIVES IN WARM-BLOODED ANIMALS.

United States Patent Karl-ll. Weber Gau-Algeshelm;

Karl Zeile, Ingelheim/Rhlne; Roll Giesemann, Bingen/Rhine; Peter B. Danneberg, lngelheim/Rhine, all of Inventors Germany Appl. No. 8 [9,940 Filed Apr. 28, 1969 Patented Nov. 30, 1971 Assignee Boehringer lngelheim Gmbll lngelheim am Rhine, Germany Priority Apr. 29, 1968 Austria A4l65/68 l-ACYL-5-PHENYL-1H-1,5-BENZODIAZEPINE- 2,4-[3u',sn -oioNEs l7 Claims, No Drawings 0.8. CI 260/239.3, 424/244 lnt. Cl C07d 53/04 Field of Search 260/2393 Bl References Cited OTHER REFERENCES Buchi et al. l-lelv. Chim. Acta" Vol. 39, pages 957- 965 (1956) Primary Examiner-Henry R. .liles Assistant ExaminerRobert T. Bond Attorney-Hammond & Littell ABSTRACT: l-Acyl-S-phenyll H-l ,5-benzodiazepine-2 4- 1.15531 ienswt'fihs m a l-ACYL-S-PHENYL- 1 lb l ,5-BENZODIAZEPHINE-2,4- [3H,5Hl-DIONES This invention relates to novel 1.-acyl-5-phenyl-lH-l, 5- benzodiazepine 2,4-[3H,5H]-diones, as well as to, a method of preparing them. 5

More particularly, the present inventionrelates to a-novel lacyl-S-phenyll H- l ,5-benzodiazepine-2,4-[3H,5H ]-diones of the formula wherein R and R have the same meanings as in formula I and X is hydrogen or an alkali metal, in the one-position. The acylation may be effected with a common acylating agent, such as an acid halide, an acid anhydride or an isocyanate, pursuant to customary methods and under reaction conditions which are usually applied to acylation reactions.

The starting compounds of the formula ll, in turn, may be prepared as described in copending application Ser. No. 703,188, filed Feb. 5, I968, that is, by cyclization of an N- phenyl-N-(2-aminophenyl)-malonic acid alkyl ester amide of the formula OR l 0 & NH: R3 /CH (III) wherein R is lower alkyl and R and R have the same meanings as in formula I. The hydrolysis and ring closure proceed smoothly and with good yields in an acid as well as an alkaline medium, preferably in the presence of an alcoholic or aqueous alcoholic solvent; however, other inert solvents suchas tetrahydrofuran or dioxan,,are also suitable; for acid cyclization, acetonitrile may also be used-a s the solvent.

Mineral acids, and particularly hydrohalic acids, such as hydrochloric acid, hydrobromic acid, hydroiodic acid, sulfuric acid. phosphoric acid and perchloric acid are preferably used as acid cyclization agents. Examples of alkaline cyclization agents are sodium alcoholates and alkali metal hydroxides.

The reaction periods depend upon the quantity of acid or alkali employed and upon the type of solvent used; they vary between several hours and several days. The reaction temperatures are preferably between +20 C. and the boiling point of the solvent'which is used.

Examples of compounds of the formula I which may be obtained by the above-described method are the following:

7-chlorol -formyl-5-phenyll H- l ,5-benzodiazepine-2,4-

[3H,5H1-dione,

l-acetyl 7-chloro-5-phenyll H- l ,5-benzodiazepine-2,4-

[3H,5H1-dione,

7-chloro-5-phenyll -propionyll H- l ,5-benzodiazepine-2,4-

[3H,5H1-dione,

7-chlorol -chloroacetyl-5-phenyl- 1 PH ,5'-benzodiazepine- 2,4-[3H,5H]-dione,

7-chloro-5-phenyl-l-trifluoroacetyl-1H-l,5-

benzodiazepine-2,4-[3H,5-dione,

7-chloro-l-cyclohexyl-carbonyl-5-phenyll H- l ,5-

benzodiazepine-2,43H,5Hl-dione, l-benzoyl-7-chloro-5-phenyll H- l ,5-benzodiazepine-2,4-

[3H, 5H1-dione, l-benzoyl-7-bromo-5-phenyl-1H-l,5-benzodiazepine-2,4-

[3H,5H,]-dione, l-benzoyl-8-methyl-5-phenyl-l H- l ,5-benzodiazepine-2,4-

[3H,5H1-dione,

l-benzoyl-5-(p-methoxyphenyl)- l H-l ,S-benzodiazepinebenzodiazepine-2,4-[3H,5H]-dione,

l-benzoyl-7-chloro-5-(p-methylphenyl)- l H- l ,5-

benzodiazepine- 2,4-[3l-l,5H]-dione,

l-benzoyl-7-chloro-5( p-chlorophenyl l H- l ,5-

benzodiazepine-2,4-[3H,5H]-dione,

benzodiapepine-2,4[3H,-5H]-dione,

7-chlorol-(o methylbenzoyl)-5-phenyll H-l ,5-

benzodiazepine-2,4-[ 3 H,5H J-dione,

7-chlorol p-methylbenzoyl)-5-phenyll H- l ,5-

benzodiazepine-2,4-[3H,5H]-dione,

7-chlorol -(o-fluorobenzoyl)-5-phenyl- 1 PM ,5-

benzodiazepine-2,4-[3H,5H]-dione,

7-chlorol -(p-nitrobenzoyl )-5-phenyll H- l ,5-

benzodiazepine-2,4-[3H,5H]-dione,

7-chlorol 3,4-dimethoxybenzoyl )-5-phenyll H- l ,5-

benzodiazepine-Z ,4-[ 3 H,5H ]-dione,

7-chlorol -(2,4-dichlorobenzoyl )-'5-phenyll H- l ,5-

benzodiazepine-2,4-[3H,5H]-dione,

7-chloro-5-phenyll -phenylacetyll H- l ,S-benzodiazepine- 7-chlorol -cinnamoyl-5-pheny|- l H-l ,S-benzodiazepine- 7-chlorol -furoyl-5-phenyll H- l ,5-benzodiazepine-2,4-

[3H,5H1-dione, 7-chloro-5-phenyll -thenoyl-'l H-l ,5-benzodiazepine-2,4-

[3H,5H1-dione,

l-ethoxy-carbonyl-7-chloro-5-phenyl- 1 1-1-1 ,5-

benzodiazepine-2,4-[3H,SH]-dione,

7-chlorol -methylcarbamoyl-5-phenyll H- l ,5-

benzodiazepine-2,4-[3H,5H]-dione,

7-chlorol -lauroyl-5-phenyll H-l ,5-benzodiazepine-2,4-

[3H,5H1dione, 7-chlorol -palmitoyl-5-phenyll'H- l ,5-benzodiazepine-2 ,4-

[3H,5H1-dione and l-benzoyl-5-phenyl-7-trifluoromethyll H- l ,5-

benzodiazepine-2,4-[3H,5H]-dione.

The following examples further illustratethe present inven- EXAMPLE 1 l-Benzoyl-7-chloro-5-phenyl- 1 PM ,5-benzodiazepine-2,4- [3H,5H1-dione 0.5 mol (154 g.) of the sodium salt of 7-chloro-5-phenyl-l H-l,5-benzodiazepine-2,4-[3H,5H]-dione were dissolved in 2 liters of tetrahydrofuran, and the solution was admixed at room temperature with 60 ml. of benzoylchloride. The mixture was refluxed for 3 hours, then evaporated, and the residue was taken up in methylenechloride. Undissolved starting material was vacuum-filtered off, and the filtrate was extracted with 300 to 500 ml. of cold water. The methylenechloride phase was dried with anhydrous magnesium sulfate and evaporated, and the residue was recrystallized twice from toluene. 1 10 g. (55 percent of theory) of benzoyl-7-chloro-5-phenyll H-1 ,5 -benzodiazepine-2,4-[ 3H,5 H]-dione, m.p. 208209 C., ofthe formula were obtained. The starting material was prepared as follows: 23 g. of sodium were dissolved in 2.3 liters of absolute alcohol, and 230 g. of N-(Z-amino-S-chlorophenyl)-N-phenyl-malonic acid ethyl ester amide were added to the solution. After 5: hours stirring at room temperature, the precipitated sodium salt was vacuum-filtered ofi, washed with cold alcohol and ether, and dried at 120 C. Yield: 200 g. (93 percent of theory).

EXAMPLE 2 l-Benzoyl-7-chloro-5 -phenyll H- l ,5 -benzodiazepine-2,4- [3H,5H1-dione 7-chloro-5-phenyll H-l ,S-benzodiazepine-Z,4-[3H,5H dione, m.p. 208-209C., were obtained.

EXAMPLE 3 7-Chloro-5-phenyll -propionyll H l ,5-benzodiazepine-2,4

[3H,51-dione 0.1 mol (28.6 g.) of 7-chloro-5-phenyl-lH-l ,5- benzodiazepine-2,4-[3H,5H]-dione were suspended in 750 ml. of absolute tetrahydrofuran, and the suspension was stirred with 5 g. of a 50 percent sodium hydride suspension in mineral oil for 2 hours at room temperature. After everything had dissolved, 13 g. of propionic acid anhydride were added, the mixture was first stirred for 2 hours at room temperature and then refluxed. After evaporation of the reaction solution in vacuo, the residue was taken up in methylene chloride, the

insoluble matter was vacuum-filtered off, and the filtrate was washed with water, and evaporated, and the residue was recrystallized from toluene. 29 g. (90 percent of theory) of 7- chloro-S-phenyll -propionyl l H-l ,5-benzodiazepine-2,4- [3H,51-dione, m.p. l94-l96 C., of the formula were obtained.

EXAMPLE 4 7-Chloro-5-phenyll-propionyll H- l ,5-benzodiazepine-2,4- [3H,5H]-dione Thereafter, the solution was evaporated in vacuo, and the raw product was worked up as described in example 1. Yield: 25.8 g. percent of the y), m.p. l94l 96 C.

EXAMPLE 5 7-Chloro-5-phenyll -propionyll H- l ,S-benzodiazepine-Z ,4- [3H,5H1-dione 0.1 mol (28.6 g.) of 7-chloro-5-phenyl-lH-l,5- benzodiazepine-2,4-[3H,5H]-dione were refluxed with 300 ml. of propionic acid anhydride for 15 hours. Subsequently, the reaction solution was evaporated in vacuo, the residue was taken up in methylenechloride, and the reaction product was isolated as described in example 1. Yield: 25.8 g. 80 percent oftheory), m.p. l94-l96 C.

EXAMPLE 6 7-Chloro-1-methylcarbamoyl-5-phenyl- 1 H- l ,5- benzodiazepine-2,4-[ 3H,5H ]-dione 0.1 mol (28.6 g.) of 7-chloro-5-phenyl-lH-l,5- benzodiazepine-2,4-[3H,5H]-dione were stirred with 850 ml. of absolute dioxane, 30 ml. of methylisocyanate and 1.5 ml. of triethylamine for 15 hours at 40 C. Thereafter, the reaction solution was evaporated in vacuo, water was added to the residue, the crystals formed thereby were vacuum-filtered off, and the filter cake was recrystallized from methylenechloride/diisopropylether. 30 g. (89 percent of theory) of 7-chloro- 1 -methylcarbamoyl-S-phenyll H- l ,5- benzodiazepine-2,4 -[3 H, 5 fil-dione, m. p. 306308 C., of the formula NHCH:

were obtained.

EXAMPLE 7 7-Chloro-5-phenyll propi onyll H- l ,5-benzodiazepine-2,4- [3H,5H1-dione 0.1 mol (28.6 g.) of 7-chloro-5-phenyl-1H-1,5- benzodiazepine-2,4-[3H,5H]-dione were refluxed with 20 g. of propionic acid anhydride in 480 ml. of xylene for 72 hours. l on The reaction solution.was allowed to cool and was then a vacuum filtered; 20 g. of the starting material were recovered 5 0:0 0 as the filter cake. By evaporating the filtrate 6 g. (19 percent of theory) of the reaction product, m.p. l94-l96 C., were isolated.

Using a procedure analogous to that described in the 10 preceding examples, the following additional compounds of the formula 1 above were prepared:

1 EXAMPLE 8 7-Chloro-5-phenyll -ethoxycarboxyll H- l ,5- benzocliazepine-2,4-[3H,5l-l]-dione, m.p. l8 188 C., of the formula from 7-chloro-5-phenyll H- l .5-benzoiazepine-2,4-[ 3H,5 H

(milk dione and o-methyl-benzoyl chloride. T 0 EXAMPLE 12 PI-C 7-Chloro-5-phenyll-(p-methyl-benzoyl)- l H- l ,5-

benzodiazepine-2,4-[3H,5H]-dione, m.p. l94l96 C., C1 I -0 from 7-chloro-5-phenyllH-l,5 benzodiozepine-2,4-[3H,5H]-

0 dione and p-methyl-benzoyl chloride.

EXAMPLE l3 dione and ethoxycarbonyl chloride.- formula EXAMPLE 9 7-Chloro-5-phenyll -formyll l-ll ,5-benzodiazepine-2,4- F [3H,5H]-dione,m.p. 2l021 1C.,ofthe formula O O H a at 0 L /cn- 1 011: 1 H Cl- N'C dione and formyl chloride.

EXAMPLE l4 EXAMPLE 7Chloro-5-phenyl-l-(cy clohexyl-carbonyl)-1H-l,5- 7-Chloro-5-phenyl-l-(o-chloro-benzoyl)-lH-l,5- benzodiazepine-2,4-[3H,5H]-dione, m.p. l57-l59 C. of the benzodiazepine-2,4-[3H,5H]-di0ne, m.p. 222-224 C., of formula the formula I I i O: /0 0:0 0 /I IC from 7-chloro-5-phenyl-lH-l,5-benzodiazepine-2,4-[3H,5H] from 7-Chloro-5-phenyl-lH-l,S-benzodiazepine-2,4-[3H,5H]

dione and o-chloro-benzoyl chloride. -dione and cyclohexyl-carbonyl chloride.

EXAMPLE ll EXAMPLE l5 7-Chloro-5-phenyll o-methyl-benzoyl l H-1 .5- 7 5 7-Chloro-5-phenyll o,p-dichlorobenzoyl l H- l ,5-

benzodiazepine-2,4-[3H,5l-l]-dione, m.p. l97- C., of the benzodiazepine-2,4-[3H,5H]-dione, m.p. 204-205 C., of the formula formula from 7-ehloro-5-phenyll H- 1 ,5-benzodiazepine-2,4-[ 3H,5 l-l dione and acetic acid anhydride.

EXAMPLE 32 7-Chloro-5-phenyll -trifluoroacetyll H- l ,5- benzodiazepine-2,4-[3H,5H]-dione, m.p. l73-l 75 C., of the formula from 7-chloro5-phenyll H- l ,5-benzodiazepine-2,4-[ 3H,5H dione and trifluoroacetic acid chloride.

EXAMPLE 33 7-Chloro-5-phenyll -lauroyl-l H- l ,5-benzodiazepine-2,4-

from 7-chloro-5-phenyll H-] ,5-benzodiazepine-2,4-[ 3H,5H dione and lauroyl chloride.

from 7-chloro-5-phenyll H-l .5-benzodiazepine-2,4-[3H,5H 1- dione and palmitic acid chloride.

The compounds according to the present invention, that is, those embraced by formula 1 above, have useful pharmacodynamic properties. More particularly, the compounds of the present invention exhibit psychosedative, muscle-relaxing and anticonvulsive activities and very low toxicity in warm-blooded animals, such as mice, rats, cats, rabbits and dogs. The psychosedative, muscle-relaxing and anticonvulsive activities of the compounds embraced by formula I were ascertained by standard pharmacological tests on laboratory animals. Compounds wherein R is phenyl, substituted phenyl, phenyl-acetyl, cyclohexyl. alkyl of one to 15 carbon atoms, chloromethyl or hydrogen, R, is hydrogen. and R is halogen or trifluoromethyl in seven-position have proved to be particu' larly efiective. More specifically, the following compounds have been found to be especially useful:

lbenzoyl-7-chloro-5-phenyll H- l ,5-benzodiazepine-2,4-

7-chlorol -cyclohexylcarbonyl-5-phenyll H-1 .5-

benzocliazepine-2,4-[3H,5H]-dione,

7-chlorol -ch1oroacetyl-$-phenyl- 1 1-1-1 ,S-benzodiazepinel-benzoyl-5-phenyl-7-trifluoromethyll H- l ,5-

benzodiazepine-2,4-[3H,5H]-dione,

7-chlorol propionyl- S-phenyl- 1H- l ,S-benzodiazepine-2,4-

[3H,5H1-dione, 7-chlorol -formyl-5-phenyll H- l ,5-benzodiazepine-2,4-

[3H,5H1-dione,

7-chlorol -phenylacetyl-5-phenyll H- l ,S-benzodiazepine- 7-chlorol 3,4-dimethoxybenzoyl)-5-phenyll H- 1 ,5-

benzodiazepine-2,4-[3H,5Hl-dione,

7-chloro l 4-methylbenzoyl )-5-phenyll H- l .5-

benzodiazepine-2,4-[3H,5H]-dione,

7-chlorol 2-fluorobenzoyl )-$-phenyll H- l ,5-

benzodiazepine-2,4-[3H,5H]-dione, 7-chlorol 4-nitrobenzoyl )-5-phenyl- 1 PM ,5-

benzodiazepine-2,4-[3H,5Hl-dione,

1-acetyl-7-chloro-5-phenyll H- l ,5-benzodiazepine-2,4-

[3H,5H1-dione,

l-benzoyl-7-bromo-5-phenyll H- l ,5-benzodiazepine-2,4-

[3H,5HJ-dione,

7-chlorol -lauroyl-5-phenyl- 1 PM ,5benzodiazepine-2,4-

[3H,5H1-dione, and

7-chlorol -palmitoyl-5 -phenyll H- l ,5-benzodiazepine-2 ,4-

[3H,5H1-dione.

For pharmaceutical purposes the compounds according to the present invention are administered to warm-blooded animals perorally or parenterally as active ingredients in customary dosage unit compositions, that is, compositions in dosage unit form consisting essentially of an inert pharmaceutical carrier and one effective dosage unit of the active ingredient such as tablets, coated pills, capsules, wafers, powders, solutions, suspensions, emulsions, syrups, suppositories and the like. One effective dosage unit of the compounds according to the present invention is from 0.0166 to 0.84 mg./kg. body weight, preferably 0.083 to 0.42 mg./kg. body weight. The daily dose is from 0.166 to 2.5 mg./kg.

The following examples illustrate a few dosage unit compositions comprising a compound of the instant invention as an active ingredient and represent the best mode contemplated of putting the invention to practical use. The parts are parts by weight unless otherwise specified.

EXAMPLE 35 Tablets The tablet composition was compounded from the following ingredients:

benzodiazepine-2.4-[3H.$Hl-dione it) part: Lactose 33 pan: Corn starch 30 parts Colloidal Illklc Compounding procedure The lactose, the corn starch and the colloidal silicic acid were thoroughly admixed with each other, the mixture was granulated with the aid of a soluble starch paste, the

benzodiazepinedione compound and the magnesium stearate were admixed with the granulate, and the composition was compressed into 75 mg. tablets. Each tablet contained mg. of the benzodiazepinedione compound and, when administered perorally to a warm-blooded animal of about 60 kg. body weight in need of such treatment, produced very good psychosedatiye, muscle-relaxing and anticonvulsive effects.

Analogous results were obtained when an equal amount of 7-chloro-l-cyclohexylcarbonyl-5-phenyl-ll-l-1,5- benzodiazepine-2,4-[3H,5l-l1-dione,

7-chlorol-chloroacetyl-S-phenyll H-l ,S-benzodiazepine- 7-chlorol -lauroyl-5-phenyll H- l ,S-benzodiazepine- 7-chloro-5-phenyll -propionyll l-ll ,5-benzodiazepine-2,4-

[3H,5l-l1-dione, 7-chlorol -formyl-5-phenyll l-ll ,5-benzodiazepine-2,4-

[3H,5H1-dione,

7-chlorol -phenylacetyl-5-phenyll H- l ,5-benzodiazepine- 7-chlorol 3 ,4-dimethoxybenzoyl )-5-phenyll H- l ,5 benzodiazepine-2,4-[ 3l-l,5l-l ]-'dione or any one of the other compounds embraced by formula I above was substituted for the particular benzodiazepinedione compounds example 35. Likewise, the amount of active ingredient in these examples may be varied to achieve the,

wherein R, is hydrogen, straight-chain alkyl of one to carbon atoms, chloromethyl, trifluoromethyl, methylamino, ethoxy, cyclohexyl, phenyl, chlorophenyl, dichlorophenyl, tolyl, dimethoxyphenyl, nitrophenyl, benzyl, styryl, thienyl or furyl, R is hydrogen, methyl, chlorine or methoxy, and

R is hydrogen, 7-chloro, 7-bromo, 8-methyl, 7-

trifluoromethyl or 8-trifluoromethyl.

2. A compound of the formula l NC\ /CH2 R;-

wherein R, is hydrogen, straight-chain alkyl of one to l5 carbon atoms, chloromethyl, phenyl, 4-methylphenyl, 3,4- dimethoxyphenyl, 2-fluorophenyl, 4-nitrophenyl, benzyl or cyclohexyl, and R,-, is hydrogen, chlorine, bromine or trifluoromethyl.

3. A compound according to claim 2, wherein R, is phenyl and R is chlorine.

4. A compound according to claim 2, wherein R, is cyclohexyl and R is chlorine.

5. A compound according to claim 2, wherein R, is chloromethyl and R is chlorine.

6. A compound according to claim 2, wherein R, is phenyl and R is trifluoromethyl.

7. A compound according to claim 2, wherein R, is ethyl and R is chlorine.

8. A compound according to claim 2, wherein R, is hydrogen and R is chlorine.

9. A compound according to claim 2, wherein R, is benzyl and R is chlorine.

10. A compound according to claim 2, wherein R, is 3,4- dimethoxyphenyl and R is chlorine.

11. A compound according to claim 2, wherein R is 4methylphenyl and R is chlorine.

12. A compound according to claim 2, wherein R, is 2- fluorophenyl and R is chlorine.

13. A compound according to claim 2, wherein R, is 4- nitrophenyl and R is chlorine.

14. A compound according to claim 2, wherein R, is methyl and R is chlorine. I

15. A compound according to claim 2, wherein R, is phenyl and R is bromine.

16. A compound according to claim 2, wherein R, is lauryl and R is chlorine.

17. A compound according to claim 2, wherein R, is palmityl and R is chlorine.

I. l III t T 23533 U NITED STATES PA'HENT CERTIFICATE OF CORR LLI'IONI Patent No. 3,62'5076 Dated November 30, 1971 Invcntods) KARL-H. WEBER, KARL ZEILE; ROLF 'GIESEMANN and LBEHG It is certified that error appears in the above-identified patent and that said Letters Patent are hereby corrected as shown below:

FCol. 1, line' 33, cancel "ps". "I

change "3H,5". --3H 26, insert before "3H- 5 &3, correct file spelling of "benzodiazepine";

. 5B, change"[3H,a5H] to --[3H,5H]--. Col. 3, line 53, change "mineral oiI L" to --tetrah drofuran-"-;

' 59, correct the spelling of "benzoyl Col. 4, line 5, change "[3H,5] to --l3H,5HJ-- Col. 5, line 15, change "ethoxycarbox'yl" to --ethoxycarbonyl--;

" 76, change "C" to -200'C-.c I

Col. 6, line 17, correct traev spell l ing 2f "benzodiaaepine Col. 7, line- 61; erase the bracket before "2".

.01. 9, line 29,- change "3H',5HAY" to --=[-3H,5H]

Col. 12, line 76, erase "Colloidal silicic". C01. 1-3, line gg, change "3H,5HAY'-DIONE( '7 to 3H,5H]-d1one;

Signed and sealed this. 6th day of .June 1972 (SEAL) Attest: I v

EDWARD. M.FLETCHER, JR. ROBERT GOT' ISCHALK Attesting Officer Commissioner of Patents I 

2. A compound of the formula wherein R1 is hydrogen, straight-chain alkyl of one to 15 carbon atoms, chloromethyl, phenyl, 4-methylphenyl, 3,4-dimethoxyphenyl, 2-fluorophenyl, 4-nitrophenyl, benzyl or cyclohexyl, and R3 is hydrogen, chlorine, bromine or trifluoromethyl.
 3. A compound according to claim 2, wherein R1 is phenyl and R3 is chlorine.
 4. A compound according to claim 2, wherein R1 is cyclohexyl and R3 is chlorine.
 5. A compound according to claim 2, wherein R1 is chloromethyl and R3 is chlorine.
 6. A compound according to claim 2, wherein R1 is phenyl and R3 is trifluoromethyl.
 7. A compound according to claim 2, wherein R1 is ethyl and R3 is chlorine.
 8. A compound according to claim 2, wherein R1 is hydrogen and R3 is chlorine.
 9. A compound according to claim 2, wherein R1 is benzyl and R3 is chlorine.
 10. A compound according to claim 2, wherein R1 is 3,4-dimethoxyphenyl and R3 is chlorine.
 11. A compound according to claim 2, wherein R1 is 4methylphenyl and R3 is chlorine.
 12. A compound according to claim 2, wherein R1 is 2-fluorophenyl and R3 is chlorine.
 13. A compound according to claim 2, wherein R1 is 4-nitrophenyl and R3 is chlorine.
 14. A compound according to claim 2, wherein R1 is methyl and R3 is chlorine.
 15. A compound according to claim 2, wherein R1 is phenyl and R3 is bromine.
 16. A compound according to claim 2, wherein R1 is lauryl and R3 is chlorine.
 17. A compound according to claim 2, wherein R1 is palmityl and R3 is chlorine. 